Patheon Total Liabilities and Share Holders Equity 2015-2017 | PTHN

Patheon total liabilities and share holders equity from 2015 to 2017. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

Patheon Total Liabilities and Share Holders Equity 2015-2017 | PTHN

Patheon total liabilities and share holders equity from 2015 to 2017. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$77B
Zoetis (ZTS)$70.7B
Takeda Pharmaceutical (TAK)$47.2B
Daiichi Sankyo, - (DSNKY)$41.5B
BeOne Medicines - (ONC)$27.8B
Sandoz Group AG (SDZNY)$24.6B
Summit Therapeutics (SMMT)$19.2B
Merck (MKKGY)$17.3B
Shionogi (SGIOY)$14.3B
United Therapeutics (UTHR)$13.5B
Neurocrine Biosciences (NBIX)$13.4B
Orion OYJ (ORINY)$11.1B
IPSEN (IPSEY)$10.3B
Stevanato Group S.p.A (STVN)$7.9B
Corcept Therapeutics (CORT)$7.6B
Madrigal Pharmaceuticals (MDGL)$7B
Ionis Pharmaceuticals (IONS)$6.7B
Grifols, S.A (GRFS)$6.7B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$4B
Hypermarcas (HYPMY)$3.2B
Crinetics Pharmaceuticals (CRNX)$3B
Catalyst Pharmaceuticals (CPRX)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.5B
Centessa Pharmaceuticals (CNTA)$2B
BioCryst Pharmaceuticals (BCRX)$1.9B
ARS Pharmaceuticals (SPRY)$1.8B
Ocular Therapeutix (OCUL)$1.8B